These changes in microbiota composition have been associated with physiological improvements, such as reduced blood glucose and insulin levels, as well as a decrease in pro-inflammatory cytokines, suggesting an anti-inflammatory effect that supports the management of obesity and related conditions [112,122]. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.